
World's First AI-Designed Vaccine Enters Human Trials at Oxford
Oxford researchers have launched human trials for the world's first AI-designed vaccine, targeting the deadly Crimean-Congo haemorrhagic fever.

Oxford researchers have launched human trials for the world's first AI-designed vaccine, targeting the deadly Crimean-Congo haemorrhagic fever.

Promising hantavirus vaccines and therapies show potential in clinical trials but face severe funding shortages to combat the deadly rodent-borne virus.

Dr. Karthick Sekar explains modern minimally invasive surgical solutions that offer faster recovery and minimal scarring for patients suffering from TMJ disorders.

WHO warns contact tracing lags at 45% as violence and travel bans hinder containment of the rare Bundibugyo Ebola strain in Congo.

The Democratic Republic of the Congo's health ministry reports a sharp decline in suspected Ebola cases following laboratory testing.

Two federal virologists face charges for allegedly smuggling deactivated mpox samples into the US and lying to airport customs officers.

Global health group CEPI allocates over $60 million to fast-track vaccines against the deadly Ebola Bundibugyo strain.

A groundbreaking trial shows a novel smart drug can shrink tumours by stripping away their ability to hide from the immune system.

Health experts warn of a potential surge in Bangladesh's measles cases following massive travel during the recent Eid holidays.

Cambodia meets 95-95-95 HIV targets, aiming to eliminate AIDS by 2030.
UNICEF airlifts critical supplies to DRC amid escalating Ebola outbreak.

New research unveils the gut-brain connection driving protein cravings, not just psychology.